Company record · updated August 5, 2026
Impel Neuropharma Inc: 8 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs April 2, 2021 to April 2, 2021.
8observations
1source filings
8verified rows
2021-04-02most recent as-of date
Source rails for this company: S-1 charter round (8).
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2021-04-02 | Series D price per share | 0.7091 USD | — | VERIFIED | "Original Issue Price" defined for Series D | 000119312521105083 |
| 2021-04-02 | Series C-3 price per share | 0.6096 USD | — | VERIFIED | "Original Issue Price" defined for Series C-3 | 000119312521105083 |
| 2021-04-02 | Series C-2 price per share | 0.5652 USD | — | VERIFIED | "Original Issue Price" defined for Series C-2 | 000119312521105083 |
| 2021-04-02 | Series C-1 price per share | 0.5289 USD | — | VERIFIED | "Original Issue Price" defined for Series C-1 | 000119312521105083 |
| 2021-04-02 | Series B price per share | 1.114 USD | — | VERIFIED | "Original Issue Price" defined for Series B | 000119312521105083 |
| 2021-04-02 | Series A-2 price per share | 0.4996 USD | — | VERIFIED | "Original Issue Price" defined for Series A-2 | 000119312521105083 |
| 2021-04-02 | Series A-1 price per share | 0.4091 USD | — | VERIFIED | "Original Issue Price" defined for Series A-1 | 000119312521105083 |
| 2021-04-02 | Series A price per share | 0.4091 USD | — | VERIFIED | "Original Issue Price" defined for Series A | 000119312521105083 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.